Alpha-GPC vs Huperzine A

Mechanism

Highly bioavailable choline source that crosses the blood-brain barrier efficiently via passive diffusion. Serves as a direct precursor for acetylcholine synthesis and phosphatidylcholine, a major structural component of neuronal membranes. Also stimulates growth hormone release via cholinergic activation of GHRH-releasing neurons in the hypothalamus. Contains ~40% choline by weight.

Standard Dosing

300-600 mg/day

Timing

Morning or pre-workout. Can be taken with or without food. Split into 1-2 doses.

Cycle Duration

Ongoing; no cycling required for standard doses

Side Effects

• GI distress
• Headache
• Dizziness
• Fishy body odor at high doses
• Potential TMAO elevation with chronic high-dose use

Contraindications

• Active peptic ulcer disease
• TMAO concerns — emerging research links high choline intake to elevated TMAO and cardiovascular risk

Best Stacking Partners

Mechanism

Potent, selective, and reversible inhibitor of acetylcholinesterase (AChE), derived from the club moss Huperzia serrata. Exhibits preference for the tetrameric G4 form of AChE predominant in the mammalian brain. Eight-fold more potent than donepezil and two-fold more potent than rivastigmine at AChE inhibition. Crosses the BBB efficiently. Also antagonizes NMDA receptors at high concentrations and provides neuroprotection via attenuation of oxidative stress, regulation of apoptotic proteins (Bcl-2, Bax, P53, caspase-3), and upregulation of NGF.

Standard Dosing

50-200 mcg twice daily

Timing

Morning and early afternoon. With or without food.

Cycle Duration

Cycle 2-4 weeks on, 1-2 weeks off to prevent AChE downregulation

Side Effects

• Nausea
• Diarrhea
• Sweating
• Blurred vision
• Muscle twitching
• Bradycardia at high doses

Contraindications

• Bradycardia
• Asthma/COPD (cholinergic bronchoconstriction)
• GI obstruction
• Concurrent use of prescription AChE inhibitors
• Peptic ulcer disease

Best Stacking Partners